CN110604835A - A composite process method for preparing vascular stent - Google Patents
A composite process method for preparing vascular stent Download PDFInfo
- Publication number
- CN110604835A CN110604835A CN201910503644.5A CN201910503644A CN110604835A CN 110604835 A CN110604835 A CN 110604835A CN 201910503644 A CN201910503644 A CN 201910503644A CN 110604835 A CN110604835 A CN 110604835A
- Authority
- CN
- China
- Prior art keywords
- layer
- rod
- electrospinning
- vascular stent
- collagen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
- D01D5/0015—Electro-spinning characterised by the initial state of the material
- D01D5/003—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
- D01D5/0061—Electro-spinning characterised by the electro-spinning apparatus
- D01D5/0076—Electro-spinning characterised by the electro-spinning apparatus characterised by the collecting device, e.g. drum, wheel, endless belt, plate or grid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/22—Materials or treatment for tissue regeneration for reconstruction of hollow organs, e.g. bladder, esophagus, urether, uterus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Textile Engineering (AREA)
- Vascular Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Materials For Medical Uses (AREA)
Abstract
本发明涉及一种制备血管支架的复合工艺方法,采用两种不同的工艺制备三层血管支架结构,内层材料为PLCL,PEG以及内皮生长因子,采用电纺丝,并形成轴向有序的纺丝;中间层为胶原蛋白,采用电化学法,制备的胶原层比胶原蛋白水凝胶更加坚实;最外层采用电纺丝,材料为PLCL,将纺丝收集为周向有序。本发明制备出的血管支架很好地模拟了天然血管地三层结构,在临床应用中具有广阔前景。
The invention relates to a composite process method for preparing vascular stents. Two different processes are used to prepare a three-layer vascular stent structure. The inner layer materials are PLCL, PEG and endothelial growth factor. Electrospinning is used to form an axially ordered structure. Spinning; the middle layer is collagen, and the prepared collagen layer is more solid than collagen hydrogel by electrochemical method; the outermost layer is electrospun, and the material is PLCL, and the spinning is collected into a circumferential order. The blood vessel stent prepared by the invention well simulates the three-layer structure of the natural blood vessel, and has broad prospects in clinical application.
Description
技术领域technical field
本发明涉及一种制备血管支架的复合工艺方法,应用于生物制造技术和组织修复领域。The invention relates to a composite process method for preparing a vascular stent, which is applied in the fields of biomanufacturing technology and tissue repair.
背景技术Background technique
心血管疾病已经成为世界上人口死亡的主要原因之一,心血管疾病的主要病因有内膜增生和血栓生成从而导致血管闭塞,一旦发生血管闭塞,就会导致距离心脏较远的组织缺血,使其丧失原本的组织功能。目前利用金属、尼龙、聚四氟乙烯等材料制备的大口径人工血管 (>6mm)在人体大中动脉缺损修复领域已获得广泛的成功,然而对于小口径的血管(<6mm) 还没有合适的解决方案,现在主要的治疗手段为血管移植,但是由于自体血管来源有限,以及异体脱细胞技术的价格昂贵,因此临床上需要大量的人工血管作为移植代替物。Cardiovascular disease has become one of the main causes of death in the world. The main causes of cardiovascular disease are intimal hyperplasia and thrombosis, which lead to vascular occlusion. Once vascular occlusion occurs, it will lead to tissue ischemia far from the heart. make it lose its original organizational function. At present, large-diameter artificial blood vessels (>6mm) made of metal, nylon, polytetrafluoroethylene and other materials have achieved extensive success in the field of human large and medium-sized artery defect repair, but there is no suitable artificial blood vessel for small-diameter blood vessels (<6mm). Solution, now the main treatment method is blood vessel transplantation, but due to the limited source of autologous blood vessels and the high price of allogeneic decellularization technology, a large number of artificial blood vessels are clinically required as transplant substitutes.
随着近些年对血管支架的广泛研究,发现目前对于血管支架最好的制备方式就是模仿天然血管的三层结构从而达到血管移植的目的,然而现在单一的技术已经很难达到适合移植的血管支架的性能要求。目前随着材料学、组织工程学、细胞生物学和临床医学等的飞速发展,使得采用复合工艺构建组织工程人工血管成为可能,也成为国内外研究的重点和热点。With the extensive research on vascular stents in recent years, it is found that the best way to prepare vascular stents is to imitate the three-layer structure of natural blood vessels to achieve the purpose of vascular transplantation. The performance requirements of the bracket. At present, with the rapid development of materials science, tissue engineering, cell biology and clinical medicine, it is possible to construct tissue-engineered artificial blood vessels using composite technology, which has become the focus and hot spot of research at home and abroad.
理想的组织工程化血管应具有如下条件:1)具有或模拟体内血管壁三层结构(即外膜、中膜和内膜);2)具有良好的生物相容性,不易产生血栓,不易发生免疫排斥反应;3)具有生物学特性,如对药物刺激有舒缩反应;4)具有血管的力学特性,即能够提供足够的强度,并具有一定的粘弹性。An ideal tissue-engineered blood vessel should have the following conditions: 1) have or simulate the three-layer structure of the blood vessel wall in vivo (ie adventitia, media and intima); 2) have good biocompatibility, and are not prone to thrombosis and Immune rejection; 3) Biological properties, such as relaxation and contraction responses to drug stimulation; 4) Mechanical properties of blood vessels, that is, they can provide sufficient strength and have certain viscoelasticity.
发明内容Contents of the invention
为了解决现阶段制备组织工程血管支架的不足,本发明的目的是提供了一种制备血管支架的复合工艺方法,从而解决单一制备工艺所带来的局限性,可以更好地模拟天然的血管以及细胞外基质,使得制备的血管支架更加符合临床医学上的各种性能的要求。In order to solve the deficiencies in the preparation of tissue engineering vascular stents at the present stage, the purpose of the present invention is to provide a composite process for preparing vascular stents, thereby solving the limitations brought by a single preparation process, and can better simulate natural blood vessels and The extracellular matrix makes the prepared stent more meet the requirements of various performances in clinical medicine.
为了达到上述的目的,本发明采用的技术方案如下:In order to achieve the above-mentioned purpose, the technical scheme that the present invention adopts is as follows:
一种制备血管支架的复合工艺方法,包括以下步骤:A composite process method for preparing vascular stents, comprising the following steps:
a.将PLCL(聚(L-乳酸-ε-己内酯))与PEG(聚乙二醇)一起溶解在体积比为1:1氯化钙和N,N-二甲基甲酰胺混合溶液中,配置成150mg/mL~350mg/mL溶液作为油相,加入载有内皮生长因子三甲基化壳聚糖作为水相,将油相和水相充分混合,搅拌至制备成稳定的水乳溶液;a. Dissolve PLCL (poly(L-lactic acid-ε-caprolactone)) and PEG (polyethylene glycol) in a mixed solution of calcium chloride and N,N-dimethylformamide at a volume ratio of 1:1 150mg/mL~350mg/mL solution is used as the oil phase, trimethylated chitosan loaded with endothelial growth factor is added as the water phase, the oil phase and the water phase are fully mixed, and stirred until a stable water emulsion is prepared solution;
b.将a中的水乳溶液装载到料筒中进行静电纺丝,用一根接收棒来收集电纺丝,制备得到厚度为200~400μm周向排列电纺丝层;b. Load the water-emulsion solution in a into the barrel for electrospinning, use a receiving rod to collect the electrospinning, and prepare a circumferentially arranged electrospinning layer with a thickness of 200-400 μm;
c.将收集到周向排列的电纺丝层用医用剪刀剪开,铺平放在盛有酒精的培养皿中,并用消过毒的方铁块压在电纺丝层上,经过2~3天的培养,然后将已经平整的电纺丝层重新卷在另外一根直径为2~3mm的电极棒上,接着将电纺丝用PLA(聚乳酸)线进行缝合,最后进行修整,得到所需的轴向排列的电纺丝;c. Cut the electrospinning layer collected in the circumferential direction with medical scissors, lay it flat in a petri dish filled with alcohol, and press it on the electrospinning layer with a sterilized square iron block. After 2~ After 3 days of cultivation, the flattened electrospun layer was rewound on another electrode rod with a diameter of 2 to 3 mm, and then the electrospun layer was sutured with PLA (polylactic acid) thread, and finally trimmed to obtain Desired axially aligned electrospinning;
d.将胶原蛋白在常温下在蒸馏水200~300mL中充分溶解并进行长时间搅拌,然后将c 中的具有缝合好内层电极棒作为负极,一个同心空心圆柱棒作为正极,通过电吸附使胶原附着在电纺层上,然后通过调控电极棒(负极)和圆柱棒(正极)之间的距离,从而获得0.4~0.5mm 的压实胶原层作为中间层;d. Fully dissolve the collagen in 200-300mL of distilled water at room temperature and stir for a long time, then use the electrode rod with a sutured inner layer in c as the negative electrode, and a concentric hollow cylindrical rod as the positive electrode. Attached to the electrospun layer, and then by adjusting the distance between the electrode rod (negative electrode) and the cylindrical rod (positive electrode), a compacted collagen layer of 0.4-0.5mm is obtained as the middle layer;
e.将d中制备电极棒(包裹着内层电纺丝和中间层胶原层)取出,去除胶原中的气泡,然后将两层膜和接收棒在酒精中浸泡2小时并照紫外灯进行消毒,然后用PBS(磷酸盐缓冲液)溶液清洗3~5次,置换出支架中残余的酒精;e. Take out the electrode rod prepared in d (wrapping the inner layer of electrospinning and the middle layer of collagen layer), remove the air bubbles in the collagen, and then soak the two layers of film and the receiving rod in alcohol for 2 hours and sterilize them by ultraviolet light , and then washed with PBS (phosphate buffer saline) solution for 3 to 5 times to replace the residual alcohol in the bracket;
f.将e中电极棒取下,再以接收棒为接收平台,再在外层电纺一层周向排列的PLCL层,最终获得三层血管支架。f. Remove the electrode rod in e, and then use the receiving rod as the receiving platform, and then electrospin a layer of circumferentially arranged PLCL layer on the outer layer, and finally obtain a three-layer vascular stent.
所述步骤a中,采用PLCL与PEG质量配比为(5~10):1,采用的油相与水相体积之比为(10~20):1。In the step a, the mass ratio of PLCL to PEG is (5-10):1, and the volume ratio of the oil phase to the water phase is (10-20):1.
在所述步骤b中制作血管支架内层时,所述接收棒的直径为2~3cm,控制接收棒接收电纺丝在轴上的接收范围长度为7~9mm,所述接收棒的材质为316L不锈钢实心电极棒。When making the inner layer of the vascular stent in the step b, the diameter of the receiving rod is 2 to 3 cm, and the length of the receiving range of the receiving rod to receive electrospinning on the shaft is 7 to 9 mm, and the material of the receiving rod is 316L stainless steel solid electrode rod.
在所述步骤b和步骤c中制作血管支架内层时,所述接收棒与针头之间的电压为10~15kv,注射速度为0.8~1.2mL/h,针头尖端到接收棒之间的距离为10~15cm,电纺1~3h。When making the inner layer of the vascular stent in the steps b and c, the voltage between the receiving rod and the needle is 10-15kv, the injection speed is 0.8-1.2mL/h, and the distance between the tip of the needle and the receiving rod 10 ~ 15cm, electrospinning 1 ~ 3h.
在所述步骤d与步骤e中制作血管支架中间层时,其电化电压为2.5~3.5V,电化时长为 30~45min,作为正极的圆柱棒为316L不锈钢空心圆柱电极棒。When making the middle layer of the vascular stent in the step d and step e, the electrochemical voltage is 2.5-3.5V, the electrochemical time is 30-45min, and the cylindrical rod as the positive electrode is a 316L stainless steel hollow cylindrical electrode rod.
在所述步骤e中放置在真空下处理电化产生的氢气和氧气气泡。The hydrogen and oxygen bubbles generated electrochemically are placed under vacuum in step e.
所述步骤f中制作血管支架外层时,控制电纺丝的电压为10~15kv,注射速度为3~5mL/h,电极棒的转速控制在800~1000r/min,针头到电极棒之间的距离为10~15cm,电纺时间为1~3h。When making the outer layer of the vascular stent in the step f, the electrospinning voltage is controlled to be 10-15kv, the injection speed is 3-5mL/h, the rotational speed of the electrode rod is controlled at 800-1000r/min, and the distance between the needle and the electrode rod is The distance is 10-15cm, and the electrospinning time is 1-3h.
本发明与现有技术相比较,具有如下显而易见的优点:Compared with the prior art, the present invention has the following obvious advantages:
1.本发明制备的血管支架采用的是具有生物相容性并可降解的生物材料,因此具有良好的生物相容性。1. The vascular stent prepared in the present invention adopts biocompatible and degradable biomaterials, so it has good biocompatibility.
2.本发明制备的血管支架内层和外层都是采用的PLCL材料,此材料拥有足够的机械强度和顺应性,而中间层采用的是电化蛋白胶原层,因此拥有足够的强度。2. Both the inner layer and the outer layer of the stent prepared by the present invention are made of PLCL material, which has sufficient mechanical strength and compliance, and the middle layer uses an electrochemical protein collagen layer, so it has sufficient strength.
3.本发明制备的血管支架的内层采用PGA(聚羟基乙酸)与PLCL材料包含内皮生长因子,其中PGA材料降解速度较快,可以快速释放内皮生长因子从而加快内皮化。3. The inner layer of the vascular stent prepared by the present invention adopts PGA (polyglycolic acid) and PLCL materials to contain endothelial growth factor, wherein the PGA material degrades faster, and can quickly release endothelial growth factor thereby accelerating endothelialization.
4.本发明制备的血管支架的内层采用轴向排列与血流方向一致,符合内皮细胞生长吸附繁殖的习性。4. The inner layer of the vascular stent prepared by the present invention adopts an axial arrangement consistent with the direction of blood flow, which conforms to the habit of endothelial cell growth, adsorption and reproduction.
5.本发明制备的血管支架的中间层采用电化胶原层,相比于普通的胶原层,此胶原层强度更高,硬度更加硬,更好的模拟了天然血管胶原层,有利于平滑肌细胞的附着。5. The middle layer of the vascular stent prepared by the present invention adopts an electrochemical collagen layer. Compared with the ordinary collagen layer, the collagen layer has higher strength and harder hardness, better simulates the natural vascular collagen layer, and is beneficial to smooth muscle cells. attached.
6.本发明制备的血管支架的外层采用周向排列的电纺层,周向排列的电纺层更加有利于平滑肌细胞的吸附。6. The outer layer of the blood vessel stent prepared in the present invention adopts the electrospun layer arranged in the circumferential direction, and the electrospun layer arranged in the circumferential direction is more conducive to the adsorption of smooth muscle cells.
附图说明Description of drawings
图1是本发明在制备血管支架内层结构采用的电纺设备结构示意图。FIG. 1 is a schematic structural view of the electrospinning equipment used in the preparation of the inner layer structure of the vascular stent according to the present invention.
图2是本发明将内层电纺丝层剪开后用铁块压着浸泡在酒精消毒的示意图。Fig. 2 is a schematic diagram of the present invention after the inner electrospinning layer is cut open and then pressed with an iron block and soaked in alcohol for disinfection.
图3是本发明在制备血管支架中间层结构采用的电化学结构示意图。Fig. 3 is a schematic diagram of the electrochemical structure used in the preparation of the middle layer structure of the vascular stent in the present invention.
图4是本发明制备血管支架的最终三层结构示意图。Fig. 4 is a schematic diagram of the final three-layer structure of the vascular stent prepared in the present invention.
在图1至图4中:In Figures 1 to 4:
1—方铁块, 2—剪开支架内层膜, 3—酒精,1—square iron block, 2—cut the inner membrane of the stent, 3—alcohol,
4—培养皿, 5—胶原蛋白溶液, 6—接收棒,4—petri dish, 5—collagen solution, 6—receiving rod,
7—PLCL与PGA混合层, 8—胶原层, 9—血管支架外层,7—PLCL and PGA mixed layer, 8—collagen layer, 9—outer layer of stent,
10—血管支架中间层, 11—血管支架内层。10—the middle layer of the blood vessel stent, 11—the inner layer of the blood vessel stent.
具体实施方式Detailed ways
以下结合附图对上述技术方案做出进一步说明,本发明得优选实施例详述如下:Below in conjunction with accompanying drawing, above-mentioned technical scheme is described further, and preferred embodiment of the present invention is described in detail as follows:
实施例一:Embodiment one:
一种制备血管支架的复合工艺方法,包括以下步骤:A composite process method for preparing vascular stents, comprising the following steps:
a.将PLCL与PEG按照质量比为5:1溶于体积比为1:1氯化钙和N,N-二甲基甲酰胺混合溶液中,配置成150mg/mL溶液作为油相,加入载有内皮生长因子三甲基化壳聚糖作为水相,将油相和水相按照10:1充分混合,搅拌至制备成稳定的水乳溶液。a. Dissolve PLCL and PEG in a mixed solution of calcium chloride and N,N-dimethylformamide with a volume ratio of 1:1 according to the mass ratio of 5:1, and prepare a 150 mg/mL solution as the oil phase, and add The endothelial growth factor trimethylated chitosan is used as the water phase, the oil phase and the water phase are fully mixed at a ratio of 10:1, and stirred until a stable water-emulsion solution is prepared.
b.将a中的水乳溶液装载到料筒中进行静电纺丝,如图1所示,用一根直径为2.5cm的 316L不锈钢实心电极棒作为接收棒来收集电纺丝,控制接收棒接收电纺丝在轴上的接收范围长度为7mm,其中接收棒与针头之间的电压为10kv,注射速度为0.8mL/h,针头尖端到接收棒之间的距离为10cm,电纺1h,制备得到厚度为150μm周向排列电纺层。b. Load the water-emulsion solution in a into the barrel for electrospinning, as shown in Figure 1, use a 316L stainless steel solid electrode rod with a diameter of 2.5cm as a receiving rod to collect the electrospinning, and control the receiving rod to receive The length of the receiving range of electrospinning on the shaft is 7mm, the voltage between the receiving rod and the needle is 10kv, the injection speed is 0.8mL/h, the distance between the tip of the needle and the receiving rod is 10cm, electrospinning for 1h, and the preparation A circumferentially aligned electrospun layer with a thickness of 150 μm was obtained.
c.将收集到周向排列的电纺丝层用医用剪刀剪开,铺平放在盛有酒精3的培养皿4中,并用消过毒的方铁块1压在电纺丝层2上,经过3天的培养,然后将已经平整的电纺丝层重新卷在直径为2mm的电极棒上,接着将电纺丝用PLA线进行缝合,最后进行修整,得到所需的轴向排列的电纺丝,如图2所示。c. Cut the electrospun layer collected in the circumferential direction with medical scissors, lay it flat on the petri dish 4 filled with alcohol 3, and press it on the electrospun layer 2 with a sterilized square iron block 1 , after 3 days of cultivation, the flattened electrospun layer was rewound on the electrode rod with a diameter of 2mm, and then the electrospun layer was sutured with PLA thread, and finally trimmed to obtain the desired axial arrangement. Electrospinning, as shown in Figure 2.
d.将胶原蛋白在常温下溶解在蒸馏水(200mL)中充分溶解并进行长时间搅拌,然后将 c中的具有缝合好内层电极棒6作为负极,一个同心空心圆柱棒9作为正极,将2.5V电压施加在两者之间,通过电吸附使胶原附着在电纺层上,通电时长控制在30分钟,然后通过调控电极棒6(负极)和圆柱棒9(正极)之间的距离,电化20min,从而获得压实胶原层8作为中间层,如图3所示。d. Collagen is fully dissolved in distilled water (200mL) at room temperature and stirred for a long time, then the electrode rod 6 with a sutured inner layer in c is used as a negative electrode, and a concentric hollow cylindrical rod 9 is used as a positive electrode, and 2.5 A voltage of V is applied between the two, and the collagen is attached to the electrospun layer by electrosorption. 20min to obtain a compacted collagen layer 8 as the middle layer, as shown in FIG. 3 .
e.将d中制备获得的两层膜及电极棒取出来放置在真空环境下去除胶原中的气泡,然后将两层膜和电极棒在酒精中浸泡2小时并照紫外灯进行消毒,然后用PBS溶液清洗5次,置换出支架中残余的酒精。e. Take out the two-layer membrane and electrode rod prepared in d and place them in a vacuum environment to remove the air bubbles in the collagen, then soak the two-layer membrane and electrode rod in alcohol for 2 hours and sterilize them with ultraviolet light, and then use The PBS solution was washed 5 times to replace the residual alcohol in the stent.
f.将e中两层膜以及接收棒取下,再以电极棒为接收平台,再在外层电纺一层周向排列的PLCL层9,其中具体的电纺条件为:电压为15kv,注射速度为3mL/h,电极棒的转速控制在800r/min,针头到电极棒之间的距离为10cm,电纺时间为1h,最终获得三层血管支架(PLCL层9,胶原层10和PLCL/PEG层),如图4所示。f. Remove the two layers of film and the receiving rod in e, and then use the electrode rod as the receiving platform, and then electrospin a layer of circumferentially arranged PLCL layer 9 on the outer layer. The specific electrospinning conditions are: the voltage is 15kv, and the injection The speed was 3mL/h, the rotational speed of the electrode rod was controlled at 800r/min, the distance between the needle and the electrode rod was 10cm, and the electrospinning time was 1h. Finally, a three-layer vascular stent was obtained (PLCL layer 9, collagen layer 10 and PLCL/ PEG layer), as shown in Figure 4.
实施例二:Embodiment two:
本实施例与实施例一基本相同,一种制备血管支架的复合工艺方法,包括以下步骤:This embodiment is basically the same as Embodiment 1, a composite process method for preparing a vascular stent, comprising the following steps:
a.将PLCL与PEG按照质量比为7:1溶于体积比为1:1氯化钙和N,N-二甲基甲酰胺混合溶液中,配置成250mg/mL溶液作为油相,加入载有内皮生长因子三甲基化壳聚糖作为水相,将油相和水相按照15:1充分混合,搅拌至制备成稳定的水乳溶液。a. Dissolve PLCL and PEG in a mixed solution of calcium chloride and N,N-dimethylformamide with a volume ratio of 1:1 according to the mass ratio of 7:1, and prepare a 250mg/mL solution as the oil phase, and add Endothelial growth factor trimethylated chitosan is used as the water phase, the oil phase and the water phase are fully mixed at a ratio of 15:1, and stirred until a stable water-emulsion solution is prepared.
b.将a中的水乳溶液装载到料筒中进行静电纺丝,用一根直径为2.5cm的316L不锈钢实心电极棒作为接收棒来收集电纺丝,控制接收棒接收电纺丝在轴上的接收范围长度为8mm,其中接收棒与针头之间的电压为10kv,注射速度为1mL/h,针头尖端到接收棒之间的距离为12cm,电纺1.5h,最终制备得到周向排列电纺层170um。b. Load the water-emulsion solution in a into the barrel for electrospinning, use a 316L stainless steel solid electrode rod with a diameter of 2.5cm as the receiving rod to collect the electrospinning, and control the receiving rod to receive the electrospinning on the shaft The length of the receiving range is 8mm, the voltage between the receiving rod and the needle is 10kv, the injection speed is 1mL/h, the distance between the tip of the needle and the receiving rod is 12cm, and the electrospinning is 1.5h. The spinning layer is 170um.
c.将收集到周向排列的电纺丝层用医用剪刀剪开,铺平放在盛有酒精3的培养皿4中,并用消过毒的方铁块1压在电纺丝层2上,经过2天的培养,然后将已经平整的电纺丝层重新卷在直径为2.5mm的电极棒上,接着将电纺丝用PLA线进行缝合,最后进行修整,得到想要的轴向排列的电纺丝。c. Cut the electrospun layer collected in the circumferential direction with medical scissors, lay it flat on the petri dish 4 filled with alcohol 3, and press it on the electrospun layer 2 with a sterilized square iron block 1 , after 2 days of cultivation, then the flattened electrospun layer was rewound on the electrode rod with a diameter of 2.5mm, then the electrospun layer was sutured with PLA thread, and finally trimmed to obtain the desired axial arrangement electrospinning.
d.将胶原蛋白在常温下溶解在蒸馏水(250mL)中充分溶解并进行长时间搅拌,然后将 c中的电极棒作为负极,再找一个同心实心圆柱棒9作为正极,将3V电压施加在两者之间,通过电吸附使胶原附着在电纺层上,通电时长控制在40分钟,然后通过调控电极棒6(负极) 和同心实心圆柱棒9(正极)之间的距离,电化40min,从而获得压实胶原层作为中间层。d. Dissolve the collagen in distilled water (250mL) at room temperature and stir it for a long time, then use the electrode rod in c as the negative electrode, find a concentric solid cylindrical rod 9 as the positive electrode, and apply a voltage of 3V between the two Between the two, the collagen is attached to the electrospun layer by electroadsorption, and the duration of electrification is controlled at 40 minutes, and then by regulating the distance between the electrode rod 6 (negative pole) and the concentric solid cylindrical rod 9 (positive pole), electrochemistry 40min, thereby Obtain a compacted collagen layer as an intermediate layer.
e.将d中制备获得的两层膜及电极棒取出来放置在真空环境下去除胶原中的气泡,然后将两层膜和电极棒在酒精中浸泡2小时并照紫外灯进行消毒,然后用PBS溶液清洗4次,置换出支架中残余的酒精。e. Take out the two-layer membrane and electrode rod prepared in d and place them in a vacuum environment to remove the air bubbles in the collagen, then soak the two-layer membrane and electrode rod in alcohol for 2 hours and sterilize them with ultraviolet light, and then use The PBS solution was washed 4 times to replace the residual alcohol in the stent.
f.将e中两层膜以及电极棒取下,再以电极棒为接收平台,再在外层电纺一层周向排列的PLCL层,其中具体的电纺条件为:电压为15kv,注射速度为4mL/h,接收棒的转速控制在900r/min,针头到接收棒之间的距离为12cm,电纺时间为2h,最终获得三层血管支架。f. Remove the two layers of film and the electrode rod in e, and then use the electrode rod as the receiving platform, and then electrospin a layer of circumferentially arranged PLCL layer on the outer layer. The specific electrospinning conditions are: voltage 15kv, injection speed The rotational speed of the receiving rod was controlled at 900r/min, the distance between the needle and the receiving rod was 12cm, and the electrospinning time was 2h. Finally, a three-layer vascular stent was obtained.
实施例三:Embodiment three:
本实施例与实施例一基本相同,一种制备血管支架的复合工艺方法,包括以下步骤:This embodiment is basically the same as Embodiment 1, a composite process method for preparing a vascular stent, comprising the following steps:
a.将PLCL与PEG按照质量比为10:1溶于体积比为1:1氯化钙和N,N-二甲基甲酰胺混合溶液中,配置成350mg/mL溶液作为油相,加入载有内皮生长因子三甲基化壳聚糖作为水相,将油相和水相按照20:1充分混合,搅拌至制备成稳定的水乳溶液。a. Dissolve PLCL and PEG in a mixed solution of calcium chloride and N,N-dimethylformamide with a volume ratio of 1:1 according to the mass ratio of 10:1, and prepare a 350 mg/mL solution as the oil phase. The endothelial growth factor trimethylated chitosan is used as the water phase, the oil phase and the water phase are fully mixed at a ratio of 20:1, and stirred until a stable water-emulsion solution is prepared.
b.将a中的水乳溶液装载到料筒中进行静电纺丝,用一根直径为3cm的316L不锈钢实心电极棒作为接收棒来收集电纺丝,控制接收棒接收电纺丝在轴上的接收范围长度为9mm,其中接收棒与针头之间的电压为15kv,注射速度为1.2mL/h,针头尖端到接收棒之间的距离为15cm,电纺3h,最终制备得到周向排列电纺层200um。b. Load the water-emulsion solution in a into the barrel for electrospinning, use a 3cm diameter 316L stainless steel solid electrode rod as a receiving rod to collect the electrospinning, and control the receiving rod to receive the electrospinning on the shaft The length of the receiving range is 9mm, the voltage between the receiving rod and the needle is 15kv, the injection speed is 1.2mL/h, the distance between the tip of the needle and the receiving rod is 15cm, the electrospinning is 3h, and finally a circumferentially arranged electrospun Layer 200um.
c.将收集到周向排列的电纺丝层用医用剪刀剪开,铺平放在盛有酒精3的培养皿4中,并用消过毒的方铁块1压在电纺丝层2上,经过3天的培养,然后将已经平整的电纺丝层重新卷在直径为3mm的电极棒6上,接着将电纺丝用PLA线进行缝合,最后进行修整,得到想要的轴向排列的电纺丝。c. Cut the electrospun layer collected in the circumferential direction with medical scissors, lay it flat on the petri dish 4 filled with alcohol 3, and press it on the electrospun layer 2 with a sterilized square iron block 1 , after 3 days of cultivation, then rewind the flattened electrospun layer on the electrode rod 6 with a diameter of 3mm, then suture the electrospun layer with PLA thread, and finally trim it to obtain the desired axial arrangement electrospinning.
d.将胶原蛋白在常温下溶解在蒸馏水(300mL)中充分溶解并进行长时间搅拌,然后将 c中的缝合好内层电极棒6作为负极,再找一个同心实心圆柱棒9作为正极,将3.5V电压施加在两者之间,通过电吸附使胶原附着在电纺层上,通电时长控制在45分钟,然后通过调控接收棒6(负极)和同心实心圆柱棒9(正极)之间的距离,电化45min从而获得压实胶原层作为中间层。d. Dissolve the collagen in distilled water (300mL) at room temperature, fully dissolve and stir for a long time, then use the sutured inner layer electrode rod 6 in c as the negative electrode, and then find a concentric solid cylindrical rod 9 as the positive electrode. A voltage of 3.5V is applied between the two, and the collagen is attached to the electrospun layer by electrosorption, and the electrification time is controlled at 45 minutes. The distance is 45min, so as to obtain a compacted collagen layer as the middle layer.
e.将d中制备获得的两层膜及电极棒取出来放置在真空环境下去除胶原中的气泡,然后将两层膜和电极棒在酒精中浸泡2小时并照紫外灯进行消毒,然后用PBS溶液清洗5次,置换出支架中残余的酒精。e. Take out the two-layer membrane and electrode rod prepared in d and place them in a vacuum environment to remove the air bubbles in the collagen, then soak the two-layer membrane and electrode rod in alcohol for 2 hours and sterilize them with ultraviolet light, and then use The PBS solution was washed 5 times to replace the residual alcohol in the stent.
f.将e中两层膜以及电极棒取下,再以电极棒为接收平台,再在外层电纺一层周向排列的PLCL层,其中具体的电纺条件为:电压为15kv,注射速度为5mL/h,电极棒的转速控制在1000r/min,针头到电极棒之间的距离为15cm,电纺时间为3h,最终获得三层血管支架。f. Remove the two layers of film and the electrode rod in e, and then use the electrode rod as the receiving platform, and then electrospin a layer of circumferentially arranged PLCL layer on the outer layer. The specific electrospinning conditions are: voltage 15kv, injection speed The rotation speed of the electrode rod was controlled at 1000r/min, the distance between the needle and the electrode rod was 15cm, and the electrospinning time was 3h. Finally, a three-layer vascular stent was obtained.
Claims (7)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910503644.5A CN110604835B (en) | 2019-06-12 | 2019-06-12 | A kind of composite process method for preparing vascular stent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910503644.5A CN110604835B (en) | 2019-06-12 | 2019-06-12 | A kind of composite process method for preparing vascular stent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN110604835A true CN110604835A (en) | 2019-12-24 |
| CN110604835B CN110604835B (en) | 2021-08-06 |
Family
ID=68890067
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910503644.5A Active CN110604835B (en) | 2019-06-12 | 2019-06-12 | A kind of composite process method for preparing vascular stent |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110604835B (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005003300A2 (en) * | 2003-06-04 | 2005-01-13 | University Of South Carolina | Tissue scaffold having aligned fibrils, apparatus and method for producing same, and methods of using same |
| CN106540327A (en) * | 2016-12-06 | 2017-03-29 | 北京航空航天大学 | A kind of three layers of artificial blood vessel bracket of imitative nature blood vessel and preparation method thereof |
| CN106955373A (en) * | 2017-03-08 | 2017-07-18 | 中原工学院 | Small calibre tissue engineering bracket material of multi-layer nano fiber and preparation method thereof |
| US20180264179A1 (en) * | 2017-03-19 | 2018-09-20 | Biohealthways, Inc. | Biodegrading implantable ocular sustained release drug delivery system |
-
2019
- 2019-06-12 CN CN201910503644.5A patent/CN110604835B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005003300A2 (en) * | 2003-06-04 | 2005-01-13 | University Of South Carolina | Tissue scaffold having aligned fibrils, apparatus and method for producing same, and methods of using same |
| CN106540327A (en) * | 2016-12-06 | 2017-03-29 | 北京航空航天大学 | A kind of three layers of artificial blood vessel bracket of imitative nature blood vessel and preparation method thereof |
| CN106955373A (en) * | 2017-03-08 | 2017-07-18 | 中原工学院 | Small calibre tissue engineering bracket material of multi-layer nano fiber and preparation method thereof |
| US20180264179A1 (en) * | 2017-03-19 | 2018-09-20 | Biohealthways, Inc. | Biodegrading implantable ocular sustained release drug delivery system |
Non-Patent Citations (2)
| Title |
|---|
| TONG WU ET AL.: "Fabrication and preliminary study of a biomimetic tri-layer tubular graft based on fibers and fiber yarns for vascular tissue engineering", 《MATERIALS SCIENCE & ENGINEERING C》 * |
| 蒋凯峰等: "电纺PLLA/PCL/PEG共混纤维膜的结构及性能", 《功能材料》 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN110604835B (en) | 2021-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12201509B2 (en) | Decellularized biologically-engineered tubular grafts | |
| US20230061170A1 (en) | Fiber scaffolds for use creating implantable structures | |
| Boland et al. | Electrospinning collagen and elastin: preliminary vascular tissue engineering | |
| CN111714706B (en) | Vascular stent capable of promoting vascular cell proliferation and secreting extracellular matrix, preparation method of vascular stent and active artificial blood vessel | |
| Wang et al. | Fabrication of small-diameter vascular scaffolds by heparin-bonded P (LLA-CL) composite nanofibers to improve graft patency | |
| Wu et al. | Tissue-engineered vascular grafts: balance of the four major requirements | |
| CN101879330A (en) | A kind of small diameter silk fibroin tubular material and preparation method thereof | |
| JP2011519616A (en) | Blood vessels by tissue engineering | |
| CN106540327A (en) | A kind of three layers of artificial blood vessel bracket of imitative nature blood vessel and preparation method thereof | |
| CN107789666A (en) | A kind of inwall micro-patterning small-caliber artificial blood vessel | |
| Guang et al. | Design and preparation of polyurethane-collagen/heparin-conjugated polycaprolactone double-layer bionic small-diameter vascular graft and its preliminary animal tests | |
| CN100531685C (en) | A kind of tissue engineering blood vessel and its in vitro construction method | |
| Yin et al. | Electrospun silk fibroin/poly (L-lactide-ε-caplacton) graft with platelet-rich growth factor for inducing smooth muscle cell growth and infiltration | |
| CN108653815A (en) | Three-dimensional coil structure and its preparation method and application with autonomous adjustment structure function | |
| Łos et al. | Successful biomaterial-based artificial organ—updates on artificial blood vessels | |
| CN111265721B (en) | Preparation method of electrostatic spinning double-layer artificial blood vessels with different diameters | |
| CN110604835B (en) | A kind of composite process method for preparing vascular stent | |
| CN118652838A (en) | A three-layer blood vessel containing a dense endothelial layer and its preparation method and application | |
| CN208974735U (en) | A composite artificial small blood vessel stent | |
| Xiong et al. | Circumferentially Aligned Electrospun Vascular Grafts Improves Its Vascular Regeneration and Remodeling in vivo | |
| CN117462759A (en) | A tissue-engineered blood vessel with excellent anticoagulant and accelerated endothelialization properties and its preparation method | |
| CN107715179A (en) | Composite artificial minute vessel stent and preparation method thereof | |
| CN117065096B (en) | Rapid preparation method and application of biological film | |
| Al-Salihi et al. | Electrospun Small-Diameter Silk Fibroin Vascular Grafts with Tuned Mechanical and Biocompatibility Properties as Tissue Engineered Scaffolds [Doctoral dissertation] | |
| Elshabrawy et al. | Vascular tissue regeneration |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |